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The present work is aimed at developing nutraceutical formulations based on the mycelium of Agaricus
bisporus and Pleurotus ostreatus, highlighting the potential of in vitro culture as a tool to improve the pro-
duction of bioactive compounds, namely phenolic acids and ergosterol. The mycelia of both species
were cultured in diﬀerent solid and liquid media in order to compare the growth rate and yielded
biomass. Fruiting bodies, mycelia and culture media were compared regarding the antioxidant activity,
anti-inﬂammatory eﬀects in RAW264.7 cells and cytotoxicity in human tumor cell lines and non-tumor
porcine liver cells. P. ostreatus mycelia showed higher contents of ergosterol and phenolic compounds,
and stronger antioxidant activity than the corresponding fruiting body. P. ostreatus and A. bisporus did not
show anti-inﬂammatory activity, and P. ostreatus was the only one showing cytotoxicity in tumor cell
lines. The results show that these mushrooms provide compounds with antioxidant and cytotoxic
capacities, with variations among species.
1. Introduction
In recent decades, the demands of consumers in terms of food
production have changed considerably. Consumers increas-
ingly believe that food directly contributes to their health and
well-being. Today’s foods are not only intended to satisfy
hunger and provide the necessary nutrients, but also to
prevent disease and improve the physical and mental well-
being of consumers.
In this context, functional foods play a very important role.
The growing demand for such foods can be explained by the
rapid advances in science and technology, increasing health
care costs, changes in eﬀective food laws tam labels and
product claims, the steady increase in life tenancy, the desire
of older people to improving the quality of life in their late
years and increased interest in maintaining good health
through diet.1 The subjects “nutraceuticals” and “functional
foods” are experiencing a broad discussion in the scientific
community, and with the recent improvements and biotechno-
logical discoveries over the last few decades, they have become
hot research topics.
According to DeFelice2 and subsequent references, “a nutra-
ceutical is any substance that is a food or a part of food and
provides medical or health benefits, including the prevention
and treatment of disease”.2 Foods, known as “functional
foods,” are thought to provide benefits beyond basic nutrition
and may play a role in reducing or minimizing the risk of
certain diseases and other health conditions.3 Nutraceuticals
and functional characteristics of many traditional foods are
being discovered and studied, while new food products are
being developed to include beneficial components. By
knowing which foods can provide specific health benefits, we
can make food and beverage choices that allow us to take
greater control of our health.
Agaricus bisporus (J.E. Lange) Imbach and Pleurotus ostreatus
(Jacq. Ex Fr.) P. Kumm., belonging to the phylum
Basidiomycota, as well as other species of cultivated edible
mushrooms, are a good source of natural antioxidants, pres-
enting in their constitution phenolic compounds, especially
phenolic acids, followed by tocopherols (mainly α-tocopherol),
ascorbic acid and carotenoids, especially β-carotene.4,5
A. bisporus, known as “champignon”, “white mushroom” or
“white button mushroom” has demonstrated valuable medi-
cinal properties including antitumor, anti-aromatase, anti-
microbial, immunomodulatory, anti-inflammatory and anti-
oxidant activities.6 P. ostreatus, better known as “oyster mush-
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room” or “repolgas” is among the most consumed mushrooms
all over the world, due to its easy production and quick growth
but also due to its organoleptic, nutritional and medicinal pro-
perties.7 The latter include immunologic, antitumor, anti-
inflammatory and antimicrobial activities, among others.8,9
The great majority of the studies reporting mushroom pro-
perties are conducted with the fruiting bodies, but culture
media used in mushroom cultivation have also been explored
as potential sources of bioactive compounds.10 On the other
hand, the in vitro culture of mycelia is becoming a promising
alternative to obtain sources of bioactive compounds, mainly
due to the shorter incubation time and easier culture con-
ditions (less space needed, low probability of contamination
and higher biomass yields when compared with fruiting
bodies).11
The fruiting bodies and mycelia of A. bisporus and
P. ostreatus were previously studied for their chemical compo-
sition, and antioxidant, anti-inflammatory and cytotoxic activi-
ties, after being harvested at diﬀerent periods.4,12–17 However,
the present study goes further and compares fruiting bodies,
mycelia and culture media in terms of bioactive properties and
compounds. Thereby, the main objective was to develop nutra-
ceutical formulations based on the fruiting body and
mycelium of A. bisporus and P. ostreatus, as also the corres-
ponding culture media, highlighting the potential of in vitro
culture as a tool to improve the production of bioactive com-
pounds by two diﬀerent mushroom species.
2. Materials and methods
2.1. Samples and mycelium production
Agaricus bisporus (J.E. Lange) Imbach was bought from a local
food store and Pleurotus ostreatus (Jacq. ex Fr.) P. Kumm. was
obtained from a sterile wheat grain and boiled wheat straw
cultivation bale in Bragança.
Mycelia from each of the mushrooms were isolated from
sporocarps in two solid and liquid media: (1) modified Melin-
Norkrans solid (incomplete medium with agar and without
micronutrients, casamino acids and malt extract) (MMNi
solid) and liquid medium (incomplete medium without agar,
micronutrients, casamino acids and malt extract) (MMNi
liquid); (2) Potato Dextrose Agar (PDA) solid medium and
Potato Dextrose Broth (PDB) liquid medium.18,19
The strains were maintained on Petri dishes (9 cm dia-
meter) containing 10 mL of solid media and flasks with 20 mL
of medium at 25 °C in the dark and cultured until mycelium
covered most of the medium: approximately 21 days for
P. ostreatus in solid medium and 42 days in liquid medium;
and 56 days for A. bisporus in solid and liquid media. Radial
growth measurements were registered every week from the
inoculation time until the full growth of the mycelium (cover-
ing all the available area).18,19 After diﬀerent growth times
mycelia were recovered from both solid and liquid media.
Fruiting bodies and mycelia were lyophilized (FreeZone 4.5,
Labconco, MO, USA) and ground to a fine powder (20 mesh).
2.2. Standards and reagents
The solvents acetonitrile 99.9% and methanol were of high-
performance liquid chromatography (HPLC) grade from Lab-
Scan (Lisbon, Portugal). The standards of ergosterol, phenolic
compounds (gallic, protocatechuic, p-hydroxybenzoic and
p-coumaric acids), cinnamic acid and trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid) were purchased from
Sigma (St Louis, MO, USA). 2,2-Diphenyl-1-picrylhydrazyl
(DPPH) was obtained from Alfa Aesar (Ward Hill, MA, USA).
Dulbecco’s modified Eagle’s medium, Hank’s balanced salt
solution (HBSS), fetal bovine serum (FBS), L-glutamine, trypsin-
EDTA, and penicillin/streptomycin solution (100 U mL−1 and
100 mg mL−1, respectively) were purchased from Gibco
Invitrogen Life Technologies (Paisley, UK). Sulforhodamine B,
trypan blue, trichloroacetic acid (TCA), lipopolysaccharide (LPS)
and Tris were purchased from Sigma Chemical Co. (Saint Louis,
MO, USA). RAW264.7 cells were purchased from ECACC
(European Collection of Animal Cell Culture, Salisburg, UK),
and DMEM medium from HyClone (GE Healthcare Life
Sciences, Logan, UT, USA). The Griess Reagent System Kit was
purchased from Promega, and dexamethasone from Sigma.
Thiamine, casamino acids, malt extract and agar were obtained
from Panreac AppliChem (Barcelona, Spain). PDA and PDB were
acquired from Oxoid microbiology products (Hampshire,
United Kingdom). All other reagents and solvents were of
analytical grade and obtained from common sources. Water
was treated in a Milli-Q water purification system (TGI Pure
Water Systems, Greenville, SC, USA).
2.3. Preparation of the extracts
Dried powder of each sample was placed in a beaker (≈2 g)
and was extracted by magnetic stirring with methanol (30 mL)
at 25 °C and 150 rpm, for 1 h. The extract was separated from
the residue by filtration through Whatman paper No. 4 into a
round flask. The residue was re-extracted once more under the
same conditions and the filtrates were combined and concen-
trated with a rotary evaporated at ≈40 °C (rotary evaporator,
Büchi, Flawil Switzerland). The extraction yield was calculated
by measuring the extract weight in relation to the initial mass
sample and stock solutions were prepared for the subsequent
bioactive assays.12 For phenolic and ergosterol compositions
the extracts were dissolved in methanol at a concentration of
20 mg mL−1 and filtered through a 0.22 μm nylon disposable
filter.
2.4. Chemical characterization
2.4.1. In terms of phenolic acids. The phenolic acid ana-
lysis was performed using a Shimadzu 20A series ultra-fast
liquid chromatograph (UFLC, Shimadzu Corporation, Kyoto,
Japan) coupled with a diode array detector.12 The phenolic
acids were identified by comparison with phenolic acid stan-
dards and quantified by comparing the area of their peaks
recorded at 280 nm with calibration curves (5–100 µg mL−1)
obtained from commercial standards. The results were
expressed as µg per g of extract.
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2.4.2. In terms of ergosterol. Ergosterol analysis was per-
formed by high performance liquid chromatography coupled
with an ultraviolet detector (HPLC-UV). The detection was per-
formed at 285 nm and data were analyzed using Clarity 2.4
Software (DataApex). Ergosterol was quantified by comparing
the area of its peak with the calibration curve obtained from a
commercial standard. The results were expressed in mg per g
of extract.20
2.5. Evaluation of the bioactive properties
2.5.1. Antioxidant activity. The crude extracts were dis-
solved in methanol obtaining stock solutions (20–80 mg mL−1),
and then subjected to serial dilutions (40 and 0.02 mg mL−1),
depending on the stock solutions and according to the assay.
The in vitro antioxidant activity of the extracts was evaluated by
performing four diﬀerent assays: DPPH radical-scavenging
activity, reducing power, β-carotene bleaching inhibition and
thiobarbituric acid reactive substance (TBARS) assay.21,22 Trolox
was used as the positive control and the results were expressed
as EC50 values (sample concentration that achieved 50% of anti-
oxidant activity or 0.5 absorbance in reducing power assay).
2.5.2. Anti-inflammatory activity. For the anti-inflamma-
tory activity assay, the methanolic extracts were dissolved in
water at a concentration of 10 mg mL−1. For the various assays,
the extracts were then subjected to further dilutions from
10 mg mL−1 to 0.16 mg mL−1. Dexametazona was used as the
positive control. The mouse macrophage-like cell line RAW
264.7 was used with a view to assessing the anti-inflammatory
activity following a procedure previously reported.15 For the
determination of nitric oxide, a Griess Reagent System kit was
used. The nitric oxide produced was determined by measuring
the absorbance at 540 nm (microplate reader ELX800 Biotek).
The percentage of inhibition of the NO production was calcu-
lated for each sample concentration. The results were
expressed as percent inhibition of NO production compared to
the negative control, and EC50 values (concentration of the
sample that provides 50% inhibition of NO production) were
also estimated.15
2.5.3. Cytotoxic activity. For the cytotoxic activity assay, the
methanolic extracts were dissolved in water at a concentration
of 10 mg mL−1. For the various assays, the extracts were then
subjected to further dilutions from 10 mg mL−1 to 0.16
mg mL−1. Ellipticine was used as the positive control. Four
human tumor cell lines were used: MCF-7 (breast adeno-
carcinoma), NCI-H460 (non-small cell lung cancer), HeLa
(cervical carcinoma) and HepG2 (hepatocellular carcinoma). The
cell density determination was performed using a sulforhodamine
B assay. The absorbance was measured at 540 nm and the
results were expressed as GI50 values (sample concentration
that inhibited 50% of the net cell growth) in µg per mL.23 For
evaluation of the cytotoxicity in non-tumor cells, a cell culture
from freshly harvested porcine liver and obtained from a local
slaughterhouse was prepared according to the procedure
described by Abreu et al.24 and referred to as PLP2. The
sulforhodamine B colorimetric assay was also followed.
2.6. Statistical analysis
For each culture component, fruiting body, mycelium and
culture medium, three independent samples were analysed
and all assays were carried out in triplicate. Data were
expressed as mean ± standard deviation. All statistical tests
were performed at a 5% significance level using IBM SPSS
Statistics for Windows, version 23.0 (IBM Corp., Armonk, NY,
USA). The fulfilment of the one-way ANOVA requirements,
specifically the normal distribution of the residuals (data not
shown) and the homogeneity of variance, was tested by means
of Shapiro Wilk’s and Levene’s tests, respectively. All depen-
dent variables were compared using Tukey’s honestly signifi-
cant diﬀerence (HSD) or Tamhane’s T2 multiple comparison
tests, when homoscedasticity was verified or not, respectively.
3. Results and discussion
3.1. Mycelia production
The establishment of P. ostreatus and A. bisporus in vitro
allowed the evaluation of diﬀerential growth rates and chemi-
cal characterization in two culture media and under two
diﬀerent physical conditions (solid vs. liquid). In vitro pro-
duction of mycelium can help to overcome diﬃculties associ-
ated with mushroom’s availability related to its seasonality or
adverse climatic conditions, being an important methodology
for continuous production of mycelia with uniform character-
istics, contaminant free and of high quality for food and
pharmaceutical purposes.25
At the industrial level, the mycelia growth rate and pro-
duced biomass are of extreme importance and both indicators
are shown in Fig. 1 and 2, respectively. As it can be observed,
after 7 days, the species P. ostreatus showed good growth on
both media (PDA and MMNi solid medium). Mycelia were
depigmented and cottony, and in PDA mycelia appeared as a
thin layer. The mycelia showed faster radial growth on PDA
and a higher biomass than on solid MMNi (fresh and dry
weight). At the end of 3 weeks the entire plate was already
covered with mycelia and the growth remained constant.
However, in liquid PDB and MMNi mycelia started growing
at day 8, and presented the same characteristics than in solid
media. In four weeks some of the mycelia already covered the
PDB medium plate, but in liquid MMNi they stopped growing
and did not cover the plate, presenting half of the diameter
of PDB. In PDB liquid medium the P. ostreatus mycelia had a
higher growth rate and biomass than in liquid MMNi
(fresh and dry weight). A. bisporus mycelia showed little growth
in all media (PDA, PDB, solid and liquid MMNi). This species
presented depigmented and rhizomorphic mycelia. This species
started growing in solid medium after 7 days. The mycelia grew
in very small diameters and also grew into the culture medium,
which made it diﬃcult to collect the mycelia; to solve this
problem, mycelia were cultivated with cellophane paper.
The radial growth was faster in MMNi than in PDA, despite
the similarities in the produced biomass (fresh and dry
weight). They stopped growing within 6 weeks and did not
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cover the plate. In MMNi liquid medium they started growing
from day 14, but in PDB they started just 1 week after MMNi.
To stimulate growth, agitation was performed and, as a result
the mycelium grew as small grains. The radial growth and
fresh weight biomass were higher in MMNi than in PDB,
although in PDB it showed higher dry weight biomass. They
stopped growing within 8 weeks and didn’t cover the plate.
The main distinctive feature considering both radial growth
patterns is that P. ostreatus exhibited very fast initial growth in
both media, although slower under liquid conditions reaching
maximum radial growth after 14 days in solid medium while
A. bisporus showed a slower and continuous growth rate along
the 56 day period of culture, never reaching the complete top
covering of the media. Although radial growth was higher in
solid than in liquid media for both species, biomass pro-
duction was higher in liquid than in solid media being similar
in composition of both media for A. bisporus but better in PDB
for P. ostreatus and not very far from the biomass production
in solid PDA medium.
Under the culture conditions studied here, we can consider
better growth results in PDA and PDB media for P. ostreatus
with similar biomass production. A. bisporus exhibited similar
biomass production in both media formulations but signifi-
cantly higher under liquid conditions. After these growth
results, chemical characterization of the samples will deter-
mine the best growth conditions for our main purposes.
3.2. Chemical characterization of the extracts
Mycelia, culture media (liquid culture media in which mycelia
were grown) and fruiting bodies were compared in terms of
bioactive compounds and properties.
The phenolic acid and ergosterol contents are presented in
Table 1. The highest content of ergosterol was found in the
fruiting body of A. bisporus (17.4 ± 0.1 mg g−1 extract); as
expected, it was not found in the culture media.
However, for P. ostreatus it was the mycelium cultivated in
the PDB medium that showed a higher quantity (18.56 ±
0.07 mg g−1 extract). The analysis of ergosterol in these mush-
room species was previously conducted by Villares et al.26 No
ergosterol was also found in the PDB culture medium.
In general and comparing mycelia, A. bisporus showed lower
contents of ergosterol (ranging from MMNi solid – 2.87 ± 0.04 to
PDB – 3.71 ± 0.04 mg g−1 extract) than P. ostreatus (ranging from
MMNi liquid – 9.08 ± 0.03 to PDB – 18.56 ± 0.07 mg g−1 extract).
But in fruiting bodies, it was A. bisporus (17.4 ± 0.1 mg g−1
extract) that showed a higher content of ergosterol in compari-
son with P. ostreatus (9.7 ± 0.2 mg g−1 extract).
Among the phenolic acids, p-hydroxybenzoic and cinnamic
acids were the major compounds in both mushrooms and in
all samples. p-Hydroxybenzoic acid in mycelium grown in
PDA reached quantities nearly five times higher in A. bisporus
(1030 ± 59 μg g−1 extract) than in P. ostreatus (188 ± 34 μg g−1
Fig. 1 Radial growth of A. bisporus (A) and P. ostreatus (B) mycelia cultivated in diﬀerent culture media throughout time.
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Fig. 2 Total biomass of A. bisporus (A) and P. ostreatus (B) mycelia.
Table 1 Ergosterol (mg g−1 extract) and phenolic acid (μg g−1 extract) contents in the mycelia and culture media of A. bisporus and P. ostreatus
Ergosterol Protocatechuic acid p-Hydroxybenzoic acid p-Coumaric acid Cinnamic acid
Agaricus bisporus
Fruiting body (edible) 17.4 ± 0.1 nd 129 ± 3 17.9 ± 0.7 15.3 ± 0.1
MMNi liquid Mycelium 3.27 ± 0.05b nd 12.5 ± 0.1d 10.4 ± 0.2b 9.0 ± 0.1c
Culture medium nd nd 363 ± 21b nd 14 ± 3c
PDB Mycelium 3.71 ± 0.04a nd 416 ± 13b 50 ± 1b 27 ± 1b
Culture medium nd nd 56 ± 2c nd 7.87 ± 0.02d
MMNi solid Mycelium 2.87 ± 0.04c nd 10 ± 1d 24 ± 1c 2.4 ± 0.1e
PDA Mycelium 3.69 ± 0.01a nd 1030 ± 59a 241 ± 9a 134 ± 1a
p-Values (n = 54) Homoscedasticitya 0.143 — 0.052 0.029 0.072
1-way ANOVAb <0.001 — <0.001 <0.001 <0.001
Pleurotus ostreatus
Fruiting body (edible) 9.7 ± 0.2 217 ± 16 463 ± 11 165 ± 2 142.8 ± 0.4
MMNi liquid Mycelium 9.08 ± 0.03d nd 38.2 ± 0.5d nd 114.8 ± 0.3c
Culture medium 0.013 ± 0.001e nd 235 ± 8ab nd 90 ± 1d
PDB Mycelium 18.56 ± 0.07a nd 266 ± 4a nd 438 ± 2a
Culture medium nd nd 125 ± 3c nd 167 ± 3b
MMNi solid Mycelium 12.13 ± 0.03c nd 77.5 ± 0.5cd 17 ± 1 93 ± 1d
PDA Mycelium 16.0 ± 0.3b 272 ± 7 188 ± 34b nd 75 ± 5e
p-Value (n = 54) Homoscedasticitya 0.045 0.023 0.048 0.023 0.165
1-Way ANOVAb <0.001 <0.001 <0.001 <0.001 <0.001
nd – Not detected. The values corresponding to the fruiting body of both mushrooms (edible samples) are presented. Values are given as mean ±
standard deviation. aHomoscedasticity among culture components was tested by the Levene test: homoscedasticity, p > 0.05; heteroscedasticity,
p < 0.05. b p < 0.05 indicates that the mean value of at least one component diﬀers from the others (in this case, multiple comparison tests were
performed). For each culture component, means within a column with diﬀerent letters diﬀer significantly (p < 0.05).
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extract). The P. ostreatus fruiting body also showed high levels
of this phenolic acid.
The phenolic compounds obtained in the present study are
the same as those reported in the literature for A. bisporus and
P. ostreatus (except the vanillic acid that could not be found in the
present study).4 Cinnamic acid was found in the highest amount
in P. ostreatusmycelium grown on PDB (438 ± 2 μg g−1 extract).
Regarding fruiting bodies, A. bisporus and P. ostreatus
showed higher levels of p-hydroxybenzoic acid (129 ± 3 and
463 ± 11 μg g−1 extract, respectively) than those of the other
phenolic acids identified.
A. bisporus showed a higher quantity of cinnamic acid in the
mycelium produced in PDA culture medium (134 ± 1 mg g−1
extract), while P. ostreatus showed the highest concentration in
the mycelium produced in PDB (438 ± 2 mg g−1 extract).
Protocatechuic acid was not found in A. bisporus like in pre-
vious studies12 and in P. ostreatus it was only found in the
fruiting body (217 ± 16 mg g−1 extract) and in the mycelium
produced in PDA (272 ± 7 mg g−1 extract). In previous studies
protocatechuic acid in P. ostreatus was found only in the fruit-
ing body.12
A. bisporus showed higher levels of p-coumaric acid (mycelium
PDA – 241 ± 9 mg g−1 extract) when compared with P. ostreatus.
This phenolic acid was present in all samples of A. bisporus,
except in the culture media. But for P. ostreatus, it only appeared
in the fruiting body (165 ± 2 mg g−1 extract) and in the mycelium
produced in MMNi solid medium (17 ± 1 mg g−1 extract).
The diﬀerences observed between the studied samples and
the values reported in the literature are related to their genetic
variability, since they are diﬀerent strains, from diﬀerent
harvesting years and geographic locations that also comprise
diverse climatic conditions, which all have an influence on the
chemical composition.4,12 For example, Reis et al.12 described
the presence of another phenolic acid (gallic acid) in the same
mushroom species from cultivated origin. The phenolic com-
pounds and ergosterol contents cannot be directly compared
to previous studies because our results are expressed in mg g−1
extract, and other literature reports expressed the results on
the dry weight basis (mg g−1 dw).4,12,26
3.3. Antioxidant activity
The organisms are equipped against damage caused by free
radicals with several defense mechanisms acting in diﬀerent
ways. As indicated, the antioxidants are natural molecules
which prevent the uncontrolled formation of free radicals and
ROS or inhibit their reaction with biological structures, inter-
rupting the chain reaction and forming radicals having low
reactivity which are easily removed from the body.22,27
Maintaining the balance between the production of free
radicals and antioxidant cell defenses is an essential condition
for the normal functioning of the body.5 However, a balance
between ROS and antioxidant defenses can be destabilized
either by overproduction of ROS or the loss of the antioxidant
defenses of cells. This imbalance is known as oxidative stress
and, in this case, the excess ROS oxidize and can damage
lipids, proteins and DNA of the cell, leading to alteration and
inhibiting its normal function.5
The results obtained for each of the performed antioxidant
activity assays, expressed as EC50 values, are shown in Table 2.
Regarding fruiting bodies, the highest activity was obtained
in the TBARS formation inhibition assay (A. bisporus: 0.09 ±
0.01 mg mL−1; P. ostreatus: 0.090 ± 0.002 mg mL−1), followed
Table 2 Antioxidant activity (EC50 values, mg mL
−1) of the mycelia and culture media of A. bisporus and P. ostreatus
DPPH scavenging
activity
Reducing
power
β-Carotene bleaching
inhibition
TBARS formation
inhibition
Agaricus bisporus
Fruiting body (edible) 3.27 ± 0.03 0.81 ± 0.01 2.2 ± 0.1 0.09 ± 0.01
MMNi liquid Mycelium 17.7 ± 0.3b 1.98 ± 0.01c 4.4 ± 0.2ab 0.7 ± 0.1b
Culture medium 18.2 ± 0.5b 2.25 ± 0.02a 4.7 ± 0.1ab 1.4 ± 0.1a
PDB Mycelium 14.7 ± 0.1c 1.23 ± 0.01e 4.2 ± 0.4b 0.19 ± 0.01cd
Culture medium 21.8 ± 0.6a 2.11 ± 0.02b 4.9 ± 0.1a 0.36 ± 0.02c
MMNi solid Mycelium 13.31 ± 0.1d 1.58 ± 0.01d 4.5 ± 0.1ab 0.22 ± 0.003cd
PDA Mycelium 10.1 ± 0.03e 0.46 ± 0.01f 4.2 ± 0.1b 0.13 ± 0.003d
p-Value (n = 54) Homoscedasticitya 0.005 0.174 0.045 0.002
1-Way ANOVAb <0.001 <0.001 <0.001 <0.001
Pleurotus ostreatus
Fruiting body (edible) 3.2 ± 0.1 1.79 ± 0.01 0.7 ± 0.1 0.09 ± 0.002
MMNi liquid Mycelium 56.9 ± 0.6a 4.08 ± 0.06a 4.6 ± 0.2a 0.220 ± 0.001a
Culture medium 57.3 ± 0.9a 3.66 ± 0.01b 2.1 ± 0.1b 0.22 ± 0.01a
PDB Mycelium 16.87 ± 0.09d 1.85 ± 0.01c 0.70 ± 0.06d 0.04 ± 0.0004d
Culture medium 32.3 ± 0.6c 1.9 ± 0.1c 1.5 ± 0.1c 0.17 ± 0.01b
MMNi solid Mycelium 52.4 ± 1.4b 3.96 ± 0.04ª 2.4 ± 0.1b 0.18 ± 0.01b
PDA Mycelium 17.1 ± 0.4d 1.94 ± 0.01c 0.92 ± 0.01d 0.080 ± 0.001c
p-Value (n = 54) Homoscedasticitya 0.059 0.108 0.016 0.003
1-Way ANOVAb <0.001 <0.001 <0.001 <0.001
Trolox 41.68 ± 0.28 41.43 ± 1.27 18.21 ± 1.12 22.84 ± 0.74
nd – Not detected. The values corresponding to the fruiting body of both mushrooms (edible samples) are presented. Values are given as mean ±
standard deviation. aHomoscedasticity among culture components was tested by the Levene test: homoscedasticity, p > 0.05; heteroscedasticity,
p < 0.05. b p < 0.05 indicates that the mean value of at least one component diﬀers from the others (in this case, multiple comparison tests were
performed). For each culture component, means within a column with diﬀerent letters diﬀer significantly (p < 0.05).
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by β-carotene bleaching inhibition (in the case of P. ostreatus:
0.7 ± 0.1 mg mL−1) or reducing power (in the case of
A. bisporus: 0.81 ± 0.01 mg mL−1). The lowest activity was
observed in DPPH radical scavenging activity assay (P. ostrea-
tus: 3.2 ± 0.1 mg mL−1; A. bisporus: 3.27 ± 0.03 mg mL−1).
In general, the values obtained for A. bisporus (for example:
reducing power – 0.81 ± 0.01 mg mL−1 and TBARS – 0.09 ±
0.01 mg mL−1) and P. ostreatus (for example: β-carotene – 0.7 ±
0.1 mg mL−1 and TBARS- 0.09 ± 0.002 mg mL−1) fruiting
bodies represent higher antioxidant activity than that reported
previously (for example: A. bisporus: reducing power – 1.80 ±
0.03 mg mL−1 and TBARS – 2.9 ± 0.5 mg mL−1; P. ostreatus:
β-carotene – 2.7 ± 0.2 mg mL−1 and TBARS – 2.6 ± 0.9
mg mL−1) (except for DPPH in A. bisporus).12 Also, for mycelia,
the antioxidant activity of these species was higher (for
example: A. bisporus: DPPH – 10.1 ± 0.03 mg mL−1; P. ostreatus:
DPPH – 17.1 ± 0.4 mg mL−1) (except for β-carotene bleaching
inhibition assay in A. bisporus) than that reported by those
authors (for example: A. bisporus: DPPH – 40 ± 2 mg mL−1;
P. ostreatus: DPPH – 29 ± 6 mg mL−1).12
In this context, phenolic acids are described as important
compounds with antioxidant activity in mushrooms due to the
presence of OH groups in their chemical structures that are
known for their ability to scavenge free radicals.28
Regarding P. ostreatus, the DPPH scavenging activity and
β-carotene bleaching inhibition (3.2 ± 0.1 and 0.7 ± 0.1
mg mL−1, respectively) were higher than those previously
reported (5.11 ± 0.65 and 440 ± 43 mg mL−1), respectively.17
A. bisporus also showed higher radical scavenging activity
(3.27 ± 0.03 mg mL−1) and reducing power (0.81 ± 0.01 mg mL−1)
than a similar sample previously reported in the literature
(9.61 ± 0.07 mg mL−1 and 3.63 ± 0.02 mg mL−1, respectively).14
Considering the main purpose of this work, it was very
interesting to discover that the antioxidant activity measured
in the mycelia and in culture media was very close (in some
cases better) to that verified in the fruiting bodies, emphasiz-
ing the high potential of these in vitro culture produced fungal
components. In the case of the culture media, these results
have shown increased interest, since those components are
usually considered as by-products of mushroom’s cultivation.
Furthermore, the diﬀerences among the same culture media,
after being used to grow each one of the mushroom species,
indicate that the evaluated antioxidant activity is in fact due to
the mycelium, grown in it, and not due to the culture media
components. Therefore, some compounds responsible for the
antioxidant activity are released into the culture medium,
while others are maintained in the mycelium.
The culture media of P. ostreatus gave better results than the
same components of A. bisporus. P. ostreatus in PDB culture
medium showed higher β-carotene bleaching inhibition, TBARS
formation inhibition and reducing power, while A. bisporus in
MMNi culture medium gave better results in DPPH scavenging
activity and reducing power assays. On the other hand,
A. bisporus mycelia produced in liquid medium MMNi gave
the worst results compared to P. ostreatus in TBARS formation
inhibition and β-carotene bleaching inhibition assays.
3.4. Anti-inflammatory activity
The ability of both mushroom species to modulate the pro-
duction of the inflammatory mediator NO (nitric oxide) was
evaluated in RAW 264.7 macrophages by pre-treating cells with
various concentrations of their methanolic extracts (Table 3).
LPS (lipopolysaccharide) is a cell wall component of Gram-
negative bacteria, and plays a central role in the pathogenesis
of several diseases.15 Macrophages are the main components
of the innate immune system, and have essential regulation
functions under several immunopathological conditions
during the inflammatory process.29
When macrophages are exposed to LPS, the LPS binds to
receptors that activate several signaling pathways which in
turn result in the activation of NF-κB. When the NF-κB signal-
ing pathway is activated, macrophages secrete NO and pro-
inflammatory cytokines. Hence, natural agents that regulate
the production of various cytokines and suppress the over-
production of NO may have protective roles in inflammation-
related diseases such as cancer, diabetes and cardiovascular
disease.30,31 Endotoxin LPS is able to induce the production of
mediators like NO, pro-inflammatory cytokines (besides inhi-
biting anti-inflammatory cytokines) and tumor necrosis factor
in macrophages. Therefore, macrophages stimulated by LPS
have been widely used for evaluation of anti-inflammatory
activities in vitro.32 In addition, due to the reproducible
response of RAW264.7 macrophages to LPS, this cell line has
been widely used for inflammatory research.15
Although phenolic acids were the compounds identified in
the studied species, their content did not correlate with this
bioactivity, which suggests that the contribution of this kind of
compound to the anti-inflammatory activity is not relevant.
However, cinnamic acid derivatives, such as caﬀeic acid,
have been previously described to down-regulate the pro-
duction of proinflammatory cytokines in CACO-2 cells.13 In
contrast, in other studies, cinnamic acid derivatives, such as
caﬀeic acid, chlorogenic acid, ferulic acid and p-hydroxy-
benzoic acid, from an ethanolic plant extract, did not aﬀect
NO production in LPS-stimulated RAW 264.7 macrophages.33
According to the obtained results, none of the species
showed anti-inflammatory activity. But, in previous studies
presented by Moro et al.13 with methanolic extracts, A. bisporus
showed an inhibition of NO production by 30% at
0.5 mg mL−1 and P. ostreatus 15% at 0.5 mg mL−1. These
authors explain that pyrogallol that is only present in extracts
of A. bisporus, Cantharellus cibarius Fr., Craterellus cornuco-
pioides (L.) Pers. and Lactarius deliciosus (L. ex Fr.) S.F. Gray
cited by Palacios et al.13 may be partly responsible for the anti-
inflammatory activity. In the same way, pyrogallol from the
medicinal plant Emblica oﬃcinalis has been identified as one
of the active compounds responsible for the anti-inflammatory
eﬀect of E. oﬃcinalis extracts in bronchial epithelial cells.34
Synergisms between pyrogallol and other active compounds
present in the extracts, such as flavonoids or cinnamic acid
derivatives, could explain the diﬀerences in activities among
the extracts studied by the mentioned authors.
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According to the results reported by Taofiq15 for ethanolic
extracts (EC50 values), P. ostreatus (96 ± 1 mg mL
−1) showed
better results than A. bisporus (190 ± 6 mg mL−1).
3.5. Cytotoxic activity
The cytotoxic activity of A. bisporus and P. ostreatus extracts
against the four carcinoma cell lines (MCF-7, NCI-H460, HeLa
and HepG2) and against a porcine liver primary cell culture
(PLP2) is shown in Table 3.
As already stated, mushrooms are sources of several powerful
new pharmaceutical products, in particular, and most impor-
tantly for modern medicine, representing an unlimited source of
compounds with potential antitumor and immunostimulating
properties. Many of these compounds have been used for the
treatment of many health problems, including cancer.35
Only the extracts prepared from P. ostreatus samples
showed some activity against the four tumor cell lines.
A. bisporus extracts could not inhibit these cell lines (up to the
maximum assayed concentration: 400 μg mL−1 extract), i.e.,
this species did not show any antitumor potential.
The extracts of P. ostreatus samples showed similar behavior
in all cell lines (GI50 values varying from 224 ± 14 to 375.0 ±
0.1 μg mL−1). In this species, the fruiting body showed activity
only for NCI-H460 (GI50 = 306 ± 27 mg mL
−1). The mycelium
produced in MMNi liquid medium presented the highest cyto-
toxic eﬀect against HepG2. All mycelia showed some activity in
tumor cell lines, but none of the culture media showed activity.
A previous study reported the activities of A. bisporus and
P. ostreatus mycelia (methanol extract) against HepG2 (54.9 ±
2.4 and 56.3 ± 2.5 mg mL−1, respectively) and HeLa (38.7 ± 1.9
and 52.2 ± 2.5 mg mL−1, respectively).16
P. ostreatus samples that showed the highest cytotoxic
activity also showed the highest contents of phenolic acids and
ergosterol.
The extracts from A. bisporus and P. ostreatus did not exhibit
a toxic eﬀect on the non-tumor primary cell line. Interestingly,
none of the assayed culture components inhibited the growth
of the PLP2 cell line, which constitutes a good indicator for
the lack of toxicity of the mycelia and culture media of both
mushroom species in non-tumor cell lines.
Mushroom extracts can be used in combination with tra-
ditional chemotherapy or used as alternative sources for adjuvant
cancer therapy, as some of these extracts have no adverse eﬀects
and activate the cells of the immune system. The bioactive com-
pounds of mushrooms may complement classical cancer therapy
and counter the side-eﬀects of cancer, such as nausea, bone
marrow suppression, anemia, and lowered resistance.36
4. Conclusion
This study was designed to develop nutraceutical formulations
based on the mycelium of A. bisporus and P. ostreatus, as
potential alternative sources of bioactive compounds or as
ingredients to be used in applications with antioxidant, anti-
inflammatory or cytotoxic activities.
Overall, the growth rate of mycelia showed to be dependent
on the culture media. Potato dextrose agar (PDA) medium was
the best one for P. ostreatus, while solid modified Melin-
Table 3 Cytotoxic (GI50 values. μg mL−1) and anti-inﬂammatory activity (EC50 values. μg mL−1) of the mycelia and culture media of A. bisporus and
P. ostreatus
MCF-7 NCI-H460 HeLa HepG2 PLP2 RAW264.7
Agaricus bisporus
Fruiting body (edible) >400 >400 >400 >400 >400 >400
MMNi liquid Mycelium >400 >400 >400 >400 >400 >400
Culture medium >400 >400 >400 >400 >400 >400
PDB Mycelium >400 >400 >400 >400 >400 >400
culture medium >400 >400 >400 >400 >400 >400
MMNi solid Mycelium >400 >400 >400 >400 >400 >400
PDA Mycelium >400 >400 >400 >400 >400 >400
p-Value (n = 54) Homoscedasticitya — — — — — —
1-Way ANOVAb — — — — — —
Pleurotus ostreatus
Fruiting body (edible) >400 306 ± 27 >400 >400 >400 >400
MMNi liquid Mycelium 239 ± 18b 329 ± 17a 286 ± 23b 224 ± 14c >400 >400
Culture medium >400 >400 >400 >400 >400 >400
PDB Mycelium >400 >400 >400 375.0 ± 0.1a >400 >400
Culture medium >400 >400 >400 >400 >400 >400
MMNi solid Mycelium 327 ± 15a >400a >400 312 ± 21b >400 >400
PDA Mycelium 330 ± 28a 271 ± 19b 338 ± 1a 280 ± 24b >400 >400
p-Value (n = 54) Homoscedasticitya 0.262 0.118 0.054 0.293 — —
1-Way ANOVAb <0.001 <0.001 <0.001 <0.001 — —
Dexamethaxone — — — — — 15.70 ± 1.1
Ellipticine 0.91 ± 0.04 1.03 ± 0.09 1.91 ± 0.06 1.14 ± 0.21 3.22 ± 0.067 —
The values corresponding to the fruiting body of both mushrooms (edible samples) are also presented. Values are given as mean ± standard
deviation. aHomoscedasticity among culture components was tested by the Levene test: homoscedasticity, p > 0.05; heteroscedasticity, p < 0.05.
b p < 0.05 indicates that the mean value of at least one component diﬀers from the others (in this case, multiple comparison tests were per-
formed). For each culture component, means within a column with diﬀerent letters diﬀer significantly (p < 0.05).
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Norkrans medium (MMNi) proved to be the best one for
A. bisporus. The growth diameter rate was not correlated with
the biomass of mycelium; for instance, radial growth was
higher in solid than in liquid media for both species, but
biomass production was higher in liquid than in solid media.
We obtained better growth results in PDA and PDB media for
P. ostreatus with similar biomass production, while A. bisporus
exhibited similar biomass production in both media formu-
lations but significantly higher under liquid conditions.
The methanolic extracts showed several phenolic acids
(p-hydroxybenzoic acid, p-coumaric acid and protocatechuic
acid), a related compound (cinnamic acid) and ergosterol,
which have been suggested to play an important role in anti-
oxidant, anti-inflammatory and antitumor activities. In
general, P. ostreatus mycelia showed higher contents of
ergosterol. Cinnamic acid and p-hydroxybenzoic acid were also
more abundant in the fruiting body of this species. A. bisporus
mycelia produced in PDA showed higher amounts of phenolic
acids and ergosterol, but P. ostreatus had higher contents of
ergosterol, p-hydroxybenzoic acid and cinnamic acid in PDB
and protocatechuic acid in PDA.
Likewise, the antioxidant activity was also higher among
the P. ostreatus components. Extracts of A. bisporus did not
show anti-inflammatory and cytotoxic activities up to the
maximum assayed concentrations, in contrast to those
observed for the mycelia of P. ostreatus, which showed some
cytotoxicity, but also did not show anti-inflammatory activity.
P. ostreatus mycelia showed cytotoxicity for tumor cell lines,
which did not happen with the fruiting body. Furthermore,
none of the species showed toxicity against non-tumor cells.
The culture component showed diﬀerentiated activity, which
should be considered together with the growth rate and
biomass yielded for each mushroom.
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